All AbMole products are for research use only, cannot be used for human consumption.
Vunakizumab (Anti-Human IL17A Recombinant Antibody) is a recombinant human IgGκ monoclonal antibody that targets IL-17A and inhibits its interaction with the IL-17 receptor. Vunakizumab can be used to study autoimmune diseases such as psoriatic arthritis, ankylosing spondylitis, multiple sclerosis and inflammatory arthritis.
CAS Number | 1792181-33-9 |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Related IL Receptor/Related Products |
---|
IL-15-IN-1
IL-15-IN-1 is a potent and selective Interleukin 15 (IL-15) inhibitor, inhibiting the proliferation of IL-15-dependent cells with an IC50 of 0.8 μM. |
IL-17 modulator 3
IL-17 modulator 3 is an IL-17 modulator. |
IL-17 modulator 4
IL-17 modulator 4 is a proagent of IL-17 modulator 1. |
IL-17A modulator-3
IL-17A modulator-3 is a IL-17A modulator. |
IL-17 modulator 4 sulfate
IL-17 modulator 4 sulfate is a proagent of IL-17 modulator 1. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.